In the last trading session, 21.17 million Agilon Health Inc (NYSE:AGL) shares changed hands as the company’s beta touched 0.35. With the company’s per share price at $5.36 changed hands at $1.11 or 26.12% during last session, the market valuation stood at $2.21B. AGL’s last price was a discount, traded about -44.22% off its 52-week high of $7.73. The share price had its 52-week low at $1.50, which suggests the last value was 72.01% up since then. When we look at Agilon Health Inc’s average trading volume, we note the 10-day average is 5.39 million shares, with the 3-month average coming to 5.67 million.
Analysts gave the Agilon Health Inc (AGL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.90. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended AGL as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Agilon Health Inc’s EPS for the current quarter is expected to be 0.01.
Agilon Health Inc (NYSE:AGL) trade information
Instantly AGL was in green as seen at the end of in last trading. With action 31.37%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 182.11%, with the 5-day performance at 31.37% in the green. However, in the 30-day time frame, Agilon Health Inc (NYSE:AGL) is 50.14% up. Looking at the short shares, we see there were 18.56 million shares sold at short interest cover period of 2.65 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2.5, meaning bulls need a downside of -114.4% from its current market value. According to analyst projections, AGL’s forecast low is 2.5 with 2.5 as the target high. To hit the forecast high, the stock’s price needs a 53.36% surge from its current level, while the stock would need to tank 53.36% for it to hit the projected low.
Agilon Health Inc (AGL) estimates and forecasts
Year-over-year growth is forecast to reach -1.06% down from the last financial year.
Consensus estimates given by 16 financial analysts project the company’s revenue in the current quarter to hit an average of 1.5B. 16 analysts are of the opinion that Agilon Health Inc’s revenue for the current quarter will be 1.48B. The company’s revenue for the corresponding quarters a year ago was 1.6B and 1.48B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -6.23%. The estimates for the next quarter sales put growth at -0.41%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 3.29%. The 2025 estimates are for Agilon Health Inc earnings to increase by 51.44%, but the outlook for the next 5-year period is at 51.27% per year.
AGL Dividends
Agilon Health Inc is expected to release its next quarterly earnings report on 2025-Feb-24.
Agilon Health Inc (NYSE:AGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.85% of Agilon Health Inc shares while 95.62% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 97.43%. There are 95.62% institutions holding the Agilon Health Inc stock share, with CLAYTON, DUBILIER & RICE, LLC the top institutional holder. As of 2024-06-30, the company held 24.3149% of the shares, roughly 100.0 million AGL shares worth $654.0 million.
FMR LLC holds the second largest percentage of outstanding shares, with 13.8418% or 56.93 million shares worth $372.3 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC . With 33.09 shares estimated at $177.34 million under it, the former controlled 8.02% of total outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held about 7.50% of the shares, roughly 30.92 shares worth around $165.72 million.
